| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8232115 | International Journal of Radiation Oncology*Biology*Physics | 2010 | 8 Pages |
Abstract
The current class solution using moderately hypofractionated helical tomotherapy in patients with locally advanced non-small-cell lung cancer is feasible. Toxicity was acceptable and in line with other reports on intensity-modulated radiotherapy. The local progression-free survival was encouraging considering the unselected population.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Samuel M.D., Michaël M.Sc., Harijati M.D., Benedikt M.D., Koen M.Sc., Vincent M.D., PhD., Mark M.D., Ph.D., Denis M.D., Ph.D., Guy M.D., Ph.D.,